Perspectives on the Immune System in Sepsis.

Area of Science:

• Molecular Biology
• Genomics
• RNA Biology

Background:

• Septic patients display extensive molecular alterations beyond traditional biochemical markers.
• These changes originate from DNA translation and gene expression.
• Unique RNA profiles, including messenger RNA (mRNA), microRNA (miRNA), and long non-coding RNA (lncRNA), characterize sepsis.

Discussion:

• The identified RNA profiles offer novel insights into sepsis pathophysiology.
• Understanding these molecular signatures is crucial for developing targeted interventions.
• Pleiotropic molecules or drug combinations are needed to counteract these complex modifications.

Key Insights:

• Sepsis induces profound changes in gene expression, specifically altering mRNA, miRNA, and lncRNA levels.
• These RNA alterations represent a distinct molecular signature of sepsis.
• The study highlights the potential of RNA-based biomarkers in sepsis diagnosis and management.

Outlook:

• Future therapeutic strategies may involve arrays of small interfering RNAs (siRNAs).
• Personalized medicine approaches using specific small molecule panels tailored to patient subpopulations are promising.
• This research paves the way for novel, precision-based treatments for sepsis.